Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples